SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 19, 2017 /PRNewswire/ -- UnitedTherapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2017 financial results before the market opens on Wednesday, October 25, 2017.
United Therapeutics will host a teleconference
This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm. [uthr-g]
About United Therapeutics
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions.
View original content:http://www.prnewswire.com/news-releases/united-therapeutics-corporation-to-report-third-quarter-2017-financial-results-before-the-market-opens-on-wednesday-october-25-2017-300539302.html
SOURCE United Therapeutics Corporation
Subscribe to our Free Newsletters!
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...View All